{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-029787","form_type":"8-K","ticker":"SCNX","cik":"0001382574","company_name":"Scienture Holdings, Inc.","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.848447+00:00","generated_at":"2026-05-31T14:19:10.471173+00:00","sec_items":["1.01","5.03","2.01","3.02","3.03","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"TRxADE HEALTH completes merger with Scienture; issues Series X preferred convertible to common","bullets":["Closed merger with Scienture Inc. on July 25; Scienture holders get 291,555 common shares (19.99% of pre-deal float) and 6,826,713 Series X non-voting convertible preferred shares.","Company to rename to Scienture Holdings, Inc. after stockholder written consent becomes effective (20 days after information statement mailed).","Board expands to 7; Shankar Hariharan and Narasimhan Mani appointed as directors.","CEO and CFO remain; lock-up agreements prohibit transfer of shares for 180 days post preferred stock conversion.","Consulting agreements with Suren Ajjarapu (702,086 common shares) and Prashant Patel (614,325 common shares) effective upon termination of employment."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-029787","json":"https://secwatch.observer/filing/0001493152-24-029787.json","markdown":"https://secwatch.observer/filing/0001493152-24-029787.md","text":"https://secwatch.observer/filing/0001493152-24-029787.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:19:10.471173+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2da7fe9992","claim":"Shankar Hariharan was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"on July 25, 2024, the Company’s Board appointed Shankar Hariharan and Narasimhan Mani to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6ddc4edde8","claim":"Narasimhan Mani was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"on July 25, 2024, the Company’s Board appointed Shankar Hariharan and Narasimhan Mani to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1f0f534b668a218600fd8c07a352c1c488387748","claim":"Scienture Holdings, Inc. completed an acquisition involving Scienture, Inc. (closed 2024-07-25).","evidence_excerpt":"The parties consummated the Mergers on July 25, 2024.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224029787/0001493152-24-029787-index.htm","confidence":0.95,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Scienture, Inc."},{"label":"Closing","value":"2024-07-25"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}